Market Overview

Raynauds Disease - 2018 Pipeline Insights featuring Allergan, Apricus Biosciences, Covis Pharmaceuticals, and Human Stem Cells Institute -


The "Raynauds
Disease - Pipeline Insight, 2018"
drug pipelines has been added
to's offering.

report offers a comprehensive insight of the pipeline (under
development) therapeutics scenario and growth prospects across Raynauds
Disease development.

The report provides detailed coverage of
the pipeline landscape for this mechanism of action, equipped with data
from multiple sources with complete pipeline analysis by developmental
stage, associated indications, route of administration and molecule type.

Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product
profiles including (but not limited to) drug description, product
development and R&D activities encompassing clinical and pre-clinical
studies, designations, collaborations, licensing deals, grants,
technologies and patent details.

The report assesses the
active Raynauds Disease pipeline products by developmental stage,
product type, molecule type, and administration route.


  • The report provides a snapshot of the pipeline development for the
    Raynauds Disease
  • The report covers pipeline activity across the complete product
    development cycle i.e. clinical, pre-clinical and discovery stages for
    the Raynauds Disease
  • The report provides pipeline product profiles which includes product
    description, developmental activities, licensors & collaborators and
    chemical information
  • Provides pipeline assessment by monotherapy and combination therapy
    products, stage of development, route of administration, and molecule
    type for Raynauds Disease
  • The report also covers the dormant and discontinued pipeline projects
    related to the Raynauds Disease

Companies Featured

  • Allergan Plc
  • Apricus Biosciences Inc
  • Covis Pharmaceuticals Inc
  • Human Stem Cells Institute

Key Topics Covered

1. Report Introduction

Raynauds Disease Overview

3. Pipeline Therapeutics

Comparative Analysis

5. Products in Clinical Stage

Products in Pre-Clinical and Discovery Stage

7. Therapeutic

8. Inactive Products

For more
information about this drug pipelines report visit

View Comments and Join the Discussion!